nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0912	0.121	CbGbCtD
Temsirolimus—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0783	0.104	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0607	0.0803	CbGbCtD
Temsirolimus—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0607	0.0803	CbGbCtD
Temsirolimus—ABCB1—Betamethasone—ankylosing spondylitis	0.0509	0.0674	CbGbCtD
Temsirolimus—ABCB1—Prednisolone—ankylosing spondylitis	0.0502	0.0665	CbGbCtD
Temsirolimus—ABCB1—Prednisone—ankylosing spondylitis	0.0474	0.0628	CbGbCtD
Temsirolimus—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0469	0.0621	CbGbCtD
Temsirolimus—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0455	0.0602	CbGbCtD
Temsirolimus—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0356	0.0471	CbGbCtD
Temsirolimus—CYP3A4—Betamethasone—ankylosing spondylitis	0.0305	0.0404	CbGbCtD
Temsirolimus—CYP3A4—Prednisolone—ankylosing spondylitis	0.0301	0.0398	CbGbCtD
Temsirolimus—ABCB1—Dexamethasone—ankylosing spondylitis	0.0296	0.0392	CbGbCtD
Temsirolimus—CYP3A4—Prednisone—ankylosing spondylitis	0.0284	0.0376	CbGbCtD
Temsirolimus—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0279	0.0369	CbGbCtD
Temsirolimus—ABCB1—Methotrexate—ankylosing spondylitis	0.0238	0.0315	CbGbCtD
Temsirolimus—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0177	0.0235	CbGbCtD
Temsirolimus—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.000477	0.00195	CcSEcCtD
Temsirolimus—Abdominal distension—Prednisone—ankylosing spondylitis	0.000474	0.00194	CcSEcCtD
Temsirolimus—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.000473	0.00194	CcSEcCtD
Temsirolimus—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000469	0.00192	CcSEcCtD
Temsirolimus—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.000469	0.00192	CcSEcCtD
Temsirolimus—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000468	0.00191	CcSEcCtD
Temsirolimus—Erythema—Prednisolone—ankylosing spondylitis	0.000452	0.00185	CcSEcCtD
Temsirolimus—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000445	0.00182	CcSEcCtD
Temsirolimus—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000442	0.00181	CcSEcCtD
Temsirolimus—Neutropenia—Prednisone—ankylosing spondylitis	0.00044	0.0018	CcSEcCtD
Temsirolimus—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000432	0.00177	CcSEcCtD
Temsirolimus—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00043	0.00176	CcSEcCtD
Temsirolimus—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000429	0.00175	CcSEcCtD
Temsirolimus—Weight decreased—Prednisone—ankylosing spondylitis	0.000426	0.00174	CcSEcCtD
Temsirolimus—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000425	0.00174	CcSEcCtD
Temsirolimus—Depression—Prednisone—ankylosing spondylitis	0.000419	0.00171	CcSEcCtD
Temsirolimus—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000417	0.0017	CcSEcCtD
Temsirolimus—Erythema—Triamcinolone—ankylosing spondylitis	0.000415	0.0017	CcSEcCtD
Temsirolimus—Erythema—Methylprednisolone—ankylosing spondylitis	0.000414	0.00169	CcSEcCtD
Temsirolimus—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000414	0.00169	CcSEcCtD
Temsirolimus—Angioedema—Prednisolone—ankylosing spondylitis	0.000413	0.00169	CcSEcCtD
Temsirolimus—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000407	0.00166	CcSEcCtD
Temsirolimus—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000404	0.00165	CcSEcCtD
Temsirolimus—Eye disorder—Betamethasone—ankylosing spondylitis	0.000404	0.00165	CcSEcCtD
Temsirolimus—Back pain—Triamcinolone—ankylosing spondylitis	0.000402	0.00164	CcSEcCtD
Temsirolimus—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000393	0.00161	CcSEcCtD
Temsirolimus—Angiopathy—Betamethasone—ankylosing spondylitis	0.000393	0.00161	CcSEcCtD
Temsirolimus—Convulsion—Prednisolone—ankylosing spondylitis	0.000391	0.0016	CcSEcCtD
Temsirolimus—Hypertension—Prednisolone—ankylosing spondylitis	0.00039	0.00159	CcSEcCtD
Temsirolimus—Angioedema—Triamcinolone—ankylosing spondylitis	0.000379	0.00155	CcSEcCtD
Temsirolimus—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000379	0.00155	CcSEcCtD
Temsirolimus—Erythema—Dexamethasone—ankylosing spondylitis	0.000377	0.00154	CcSEcCtD
Temsirolimus—Erythema—Betamethasone—ankylosing spondylitis	0.000377	0.00154	CcSEcCtD
Temsirolimus—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00037	0.00151	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000369	0.00151	CcSEcCtD
Temsirolimus—Oedema—Prednisolone—ankylosing spondylitis	0.000369	0.00151	CcSEcCtD
Temsirolimus—Dysuria—Methotrexate—ankylosing spondylitis	0.000368	0.0015	CcSEcCtD
Temsirolimus—Neutropenia—Methotrexate—ankylosing spondylitis	0.000368	0.0015	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000366	0.0015	CcSEcCtD
Temsirolimus—Cough—Triamcinolone—ankylosing spondylitis	0.000362	0.00148	CcSEcCtD
Temsirolimus—Convulsion—Triamcinolone—ankylosing spondylitis	0.00036	0.00147	CcSEcCtD
Temsirolimus—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000359	0.00147	CcSEcCtD
Temsirolimus—Hypertension—Triamcinolone—ankylosing spondylitis	0.000359	0.00147	CcSEcCtD
Temsirolimus—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000358	0.00146	CcSEcCtD
Temsirolimus—Myalgia—Triamcinolone—ankylosing spondylitis	0.000354	0.00145	CcSEcCtD
Temsirolimus—Pneumonia—Methotrexate—ankylosing spondylitis	0.000353	0.00144	CcSEcCtD
Temsirolimus—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000353	0.00144	CcSEcCtD
Temsirolimus—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000353	0.00144	CcSEcCtD
Temsirolimus—Eye disorder—Prednisone—ankylosing spondylitis	0.000352	0.00144	CcSEcCtD
Temsirolimus—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000352	0.00144	CcSEcCtD
Temsirolimus—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000351	0.00143	CcSEcCtD
Temsirolimus—Infestation—Methotrexate—ankylosing spondylitis	0.000351	0.00143	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00035	0.00143	CcSEcCtD
Temsirolimus—Depression—Methotrexate—ankylosing spondylitis	0.00035	0.00143	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000348	0.00142	CcSEcCtD
Temsirolimus—Renal failure—Methotrexate—ankylosing spondylitis	0.000345	0.00141	CcSEcCtD
Temsirolimus—Angioedema—Dexamethasone—ankylosing spondylitis	0.000344	0.00141	CcSEcCtD
Temsirolimus—Angioedema—Betamethasone—ankylosing spondylitis	0.000344	0.00141	CcSEcCtD
Temsirolimus—Stomatitis—Methotrexate—ankylosing spondylitis	0.000342	0.0014	CcSEcCtD
Temsirolimus—Angiopathy—Prednisone—ankylosing spondylitis	0.000342	0.0014	CcSEcCtD
Temsirolimus—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000341	0.00139	CcSEcCtD
Temsirolimus—Immune system disorder—Prednisone—ankylosing spondylitis	0.00034	0.00139	CcSEcCtD
Temsirolimus—Oedema—Triamcinolone—ankylosing spondylitis	0.000339	0.00139	CcSEcCtD
Temsirolimus—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000339	0.00139	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000338	0.00138	CcSEcCtD
Temsirolimus—Infection—Triamcinolone—ankylosing spondylitis	0.000337	0.00138	CcSEcCtD
Temsirolimus—Infection—Methylprednisolone—ankylosing spondylitis	0.000336	0.00137	CcSEcCtD
Temsirolimus—Haematuria—Methotrexate—ankylosing spondylitis	0.000335	0.00137	CcSEcCtD
Temsirolimus—Insomnia—Prednisolone—ankylosing spondylitis	0.000333	0.00136	CcSEcCtD
Temsirolimus—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000332	0.00136	CcSEcCtD
Temsirolimus—Epistaxis—Methotrexate—ankylosing spondylitis	0.000331	0.00135	CcSEcCtD
Temsirolimus—Mental disorder—Prednisone—ankylosing spondylitis	0.00033	0.00135	CcSEcCtD
Temsirolimus—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000328	0.00134	CcSEcCtD
Temsirolimus—Malnutrition—Prednisone—ankylosing spondylitis	0.000328	0.00134	CcSEcCtD
Temsirolimus—Erythema—Prednisone—ankylosing spondylitis	0.000328	0.00134	CcSEcCtD
Temsirolimus—Convulsion—Dexamethasone—ankylosing spondylitis	0.000326	0.00133	CcSEcCtD
Temsirolimus—Convulsion—Betamethasone—ankylosing spondylitis	0.000326	0.00133	CcSEcCtD
Temsirolimus—Hypertension—Betamethasone—ankylosing spondylitis	0.000325	0.00133	CcSEcCtD
Temsirolimus—Hypertension—Dexamethasone—ankylosing spondylitis	0.000325	0.00133	CcSEcCtD
Temsirolimus—Myalgia—Betamethasone—ankylosing spondylitis	0.000321	0.00131	CcSEcCtD
Temsirolimus—Myalgia—Dexamethasone—ankylosing spondylitis	0.000321	0.00131	CcSEcCtD
Temsirolimus—Anxiety—Betamethasone—ankylosing spondylitis	0.00032	0.00131	CcSEcCtD
Temsirolimus—Anxiety—Dexamethasone—ankylosing spondylitis	0.00032	0.00131	CcSEcCtD
Temsirolimus—Pain—Prednisolone—ankylosing spondylitis	0.000315	0.00129	CcSEcCtD
Temsirolimus—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000313	0.00128	CcSEcCtD
Temsirolimus—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000311	0.00127	CcSEcCtD
Temsirolimus—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000309	0.00126	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000309	0.00126	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000308	0.00126	CcSEcCtD
Temsirolimus—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000307	0.00126	CcSEcCtD
Temsirolimus—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000307	0.00126	CcSEcCtD
Temsirolimus—Oedema—Betamethasone—ankylosing spondylitis	0.000307	0.00126	CcSEcCtD
Temsirolimus—Oedema—Dexamethasone—ankylosing spondylitis	0.000307	0.00126	CcSEcCtD
Temsirolimus—Insomnia—Triamcinolone—ankylosing spondylitis	0.000307	0.00125	CcSEcCtD
Temsirolimus—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000306	0.00125	CcSEcCtD
Temsirolimus—Infection—Betamethasone—ankylosing spondylitis	0.000305	0.00125	CcSEcCtD
Temsirolimus—Infection—Dexamethasone—ankylosing spondylitis	0.000305	0.00125	CcSEcCtD
Temsirolimus—Anaemia—Prednisone—ankylosing spondylitis	0.000303	0.00124	CcSEcCtD
Temsirolimus—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000302	0.00124	CcSEcCtD
Temsirolimus—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000302	0.00123	CcSEcCtD
Temsirolimus—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000302	0.00123	CcSEcCtD
Temsirolimus—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000301	0.00123	CcSEcCtD
Temsirolimus—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000301	0.00123	CcSEcCtD
Temsirolimus—Angioedema—Prednisone—ankylosing spondylitis	0.0003	0.00123	CcSEcCtD
Temsirolimus—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000298	0.00122	CcSEcCtD
Temsirolimus—Eye disorder—Methotrexate—ankylosing spondylitis	0.000294	0.0012	CcSEcCtD
Temsirolimus—Anorexia—Betamethasone—ankylosing spondylitis	0.000293	0.0012	CcSEcCtD
Temsirolimus—Anorexia—Dexamethasone—ankylosing spondylitis	0.000293	0.0012	CcSEcCtD
Temsirolimus—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000292	0.0012	CcSEcCtD
Temsirolimus—Fatigue—Triamcinolone—ankylosing spondylitis	0.000292	0.00119	CcSEcCtD
Temsirolimus—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000292	0.00119	CcSEcCtD
Temsirolimus—Pain—Triamcinolone—ankylosing spondylitis	0.00029	0.00118	CcSEcCtD
Temsirolimus—Angiopathy—Methotrexate—ankylosing spondylitis	0.000286	0.00117	CcSEcCtD
Temsirolimus—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000285	0.00116	CcSEcCtD
Temsirolimus—Convulsion—Prednisone—ankylosing spondylitis	0.000284	0.00116	CcSEcCtD
Temsirolimus—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000284	0.00116	CcSEcCtD
Temsirolimus—Hypertension—Prednisone—ankylosing spondylitis	0.000283	0.00116	CcSEcCtD
Temsirolimus—Chills—Methotrexate—ankylosing spondylitis	0.000283	0.00116	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00028	0.00115	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00028	0.00115	CcSEcCtD
Temsirolimus—Arthralgia—Prednisone—ankylosing spondylitis	0.000279	0.00114	CcSEcCtD
Temsirolimus—Myalgia—Prednisone—ankylosing spondylitis	0.000279	0.00114	CcSEcCtD
Temsirolimus—Anxiety—Prednisone—ankylosing spondylitis	0.000278	0.00114	CcSEcCtD
Temsirolimus—Insomnia—Dexamethasone—ankylosing spondylitis	0.000278	0.00114	CcSEcCtD
Temsirolimus—Insomnia—Betamethasone—ankylosing spondylitis	0.000278	0.00114	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000277	0.00113	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000277	0.00113	CcSEcCtD
Temsirolimus—Mental disorder—Methotrexate—ankylosing spondylitis	0.000276	0.00113	CcSEcCtD
Temsirolimus—Malnutrition—Methotrexate—ankylosing spondylitis	0.000274	0.00112	CcSEcCtD
Temsirolimus—Erythema—Methotrexate—ankylosing spondylitis	0.000274	0.00112	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000272	0.00111	CcSEcCtD
Temsirolimus—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000269	0.0011	CcSEcCtD
Temsirolimus—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000268	0.0011	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000268	0.00109	CcSEcCtD
Temsirolimus—Oedema—Prednisone—ankylosing spondylitis	0.000268	0.00109	CcSEcCtD
Temsirolimus—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000267	0.00109	CcSEcCtD
Temsirolimus—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000267	0.00109	CcSEcCtD
Temsirolimus—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000267	0.00109	CcSEcCtD
Temsirolimus—Infection—Prednisone—ankylosing spondylitis	0.000266	0.00109	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000265	0.00109	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000265	0.00109	CcSEcCtD
Temsirolimus—Back pain—Methotrexate—ankylosing spondylitis	0.000265	0.00108	CcSEcCtD
Temsirolimus—Fatigue—Dexamethasone—ankylosing spondylitis	0.000265	0.00108	CcSEcCtD
Temsirolimus—Fatigue—Betamethasone—ankylosing spondylitis	0.000265	0.00108	CcSEcCtD
Temsirolimus—Pain—Betamethasone—ankylosing spondylitis	0.000263	0.00107	CcSEcCtD
Temsirolimus—Pain—Dexamethasone—ankylosing spondylitis	0.000263	0.00107	CcSEcCtD
Temsirolimus—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000263	0.00107	CcSEcCtD
Temsirolimus—Skin disorder—Prednisone—ankylosing spondylitis	0.00026	0.00106	CcSEcCtD
Temsirolimus—Anorexia—Prednisone—ankylosing spondylitis	0.000255	0.00104	CcSEcCtD
Temsirolimus—Anaemia—Methotrexate—ankylosing spondylitis	0.000253	0.00104	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000251	0.00103	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000251	0.00103	CcSEcCtD
Temsirolimus—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00025	0.00102	CcSEcCtD
Temsirolimus—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000249	0.00102	CcSEcCtD
Temsirolimus—Leukopenia—Methotrexate—ankylosing spondylitis	0.000245	0.001	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000244	0.000997	CcSEcCtD
Temsirolimus—Dizziness—Prednisolone—ankylosing spondylitis	0.000244	0.000996	CcSEcCtD
Temsirolimus—Asthenia—Triamcinolone—ankylosing spondylitis	0.000243	0.000994	CcSEcCtD
Temsirolimus—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000243	0.000994	CcSEcCtD
Temsirolimus—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000243	0.000994	CcSEcCtD
Temsirolimus—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000243	0.000994	CcSEcCtD
Temsirolimus—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000243	0.000994	CcSEcCtD
Temsirolimus—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000243	0.000992	CcSEcCtD
Temsirolimus—Insomnia—Prednisone—ankylosing spondylitis	0.000242	0.00099	CcSEcCtD
Temsirolimus—Pruritus—Triamcinolone—ankylosing spondylitis	0.00024	0.00098	CcSEcCtD
Temsirolimus—Cough—Methotrexate—ankylosing spondylitis	0.000239	0.000978	CcSEcCtD
Temsirolimus—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000239	0.000978	CcSEcCtD
Temsirolimus—Convulsion—Methotrexate—ankylosing spondylitis	0.000238	0.000971	CcSEcCtD
Temsirolimus—Chest pain—Methotrexate—ankylosing spondylitis	0.000233	0.000954	CcSEcCtD
Temsirolimus—Arthralgia—Methotrexate—ankylosing spondylitis	0.000233	0.000954	CcSEcCtD
Temsirolimus—Myalgia—Methotrexate—ankylosing spondylitis	0.000233	0.000954	CcSEcCtD
Temsirolimus—Decreased appetite—Prednisone—ankylosing spondylitis	0.000233	0.000952	CcSEcCtD
Temsirolimus—Rash—Prednisolone—ankylosing spondylitis	0.000232	0.00095	CcSEcCtD
Temsirolimus—Dermatitis—Prednisolone—ankylosing spondylitis	0.000232	0.000949	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000232	0.000948	CcSEcCtD
Temsirolimus—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000231	0.000946	CcSEcCtD
Temsirolimus—Fatigue—Prednisone—ankylosing spondylitis	0.000231	0.000944	CcSEcCtD
Temsirolimus—Headache—Prednisolone—ankylosing spondylitis	0.000231	0.000944	CcSEcCtD
Temsirolimus—Constipation—Prednisone—ankylosing spondylitis	0.000229	0.000936	CcSEcCtD
Temsirolimus—Dizziness—Triamcinolone—ankylosing spondylitis	0.000224	0.000916	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000224	0.000915	CcSEcCtD
Temsirolimus—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000224	0.000914	CcSEcCtD
Temsirolimus—Infection—Methotrexate—ankylosing spondylitis	0.000222	0.000909	CcSEcCtD
Temsirolimus—Asthenia—Betamethasone—ankylosing spondylitis	0.000221	0.000902	CcSEcCtD
Temsirolimus—Asthenia—Dexamethasone—ankylosing spondylitis	0.000221	0.000902	CcSEcCtD
Temsirolimus—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000219	0.000897	CcSEcCtD
Temsirolimus—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000219	0.000896	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000219	0.000895	CcSEcCtD
Temsirolimus—Nausea—Prednisolone—ankylosing spondylitis	0.000219	0.000895	CcSEcCtD
Temsirolimus—Pruritus—Dexamethasone—ankylosing spondylitis	0.000218	0.000889	CcSEcCtD
Temsirolimus—Pruritus—Betamethasone—ankylosing spondylitis	0.000218	0.000889	CcSEcCtD
Temsirolimus—Skin disorder—Methotrexate—ankylosing spondylitis	0.000217	0.000889	CcSEcCtD
Temsirolimus—Vomiting—Triamcinolone—ankylosing spondylitis	0.000215	0.000881	CcSEcCtD
Temsirolimus—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000215	0.000879	CcSEcCtD
Temsirolimus—Rash—Triamcinolone—ankylosing spondylitis	0.000214	0.000874	CcSEcCtD
Temsirolimus—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000213	0.000873	CcSEcCtD
Temsirolimus—Anorexia—Methotrexate—ankylosing spondylitis	0.000213	0.000872	CcSEcCtD
Temsirolimus—Rash—Methylprednisolone—ankylosing spondylitis	0.000213	0.000872	CcSEcCtD
Temsirolimus—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000213	0.000871	CcSEcCtD
Temsirolimus—Headache—Triamcinolone—ankylosing spondylitis	0.000212	0.000868	CcSEcCtD
Temsirolimus—Headache—Methylprednisolone—ankylosing spondylitis	0.000212	0.000866	CcSEcCtD
Temsirolimus—Body temperature increased—Prednisone—ankylosing spondylitis	0.000212	0.000865	CcSEcCtD
Temsirolimus—Abdominal pain—Prednisone—ankylosing spondylitis	0.000212	0.000865	CcSEcCtD
Temsirolimus—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00021	0.00086	CcSEcCtD
Temsirolimus—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00021	0.00086	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000204	0.000834	CcSEcCtD
Temsirolimus—Dizziness—Betamethasone—ankylosing spondylitis	0.000203	0.000831	CcSEcCtD
Temsirolimus—Dizziness—Dexamethasone—ankylosing spondylitis	0.000203	0.000831	CcSEcCtD
Temsirolimus—Insomnia—Methotrexate—ankylosing spondylitis	0.000202	0.000827	CcSEcCtD
Temsirolimus—Nausea—Triamcinolone—ankylosing spondylitis	0.000201	0.000823	CcSEcCtD
Temsirolimus—Nausea—Methylprednisolone—ankylosing spondylitis	0.000201	0.000821	CcSEcCtD
Temsirolimus—Dyspnoea—Methotrexate—ankylosing spondylitis	0.0002	0.000816	CcSEcCtD
Temsirolimus—Somnolence—Methotrexate—ankylosing spondylitis	0.000199	0.000813	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000197	0.000807	CcSEcCtD
Temsirolimus—Vomiting—Betamethasone—ankylosing spondylitis	0.000196	0.000799	CcSEcCtD
Temsirolimus—Vomiting—Dexamethasone—ankylosing spondylitis	0.000196	0.000799	CcSEcCtD
Temsirolimus—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000195	0.000795	CcSEcCtD
Temsirolimus—Rash—Dexamethasone—ankylosing spondylitis	0.000194	0.000793	CcSEcCtD
Temsirolimus—Rash—Betamethasone—ankylosing spondylitis	0.000194	0.000793	CcSEcCtD
Temsirolimus—Dermatitis—Betamethasone—ankylosing spondylitis	0.000194	0.000792	CcSEcCtD
Temsirolimus—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000194	0.000792	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000193	0.00079	CcSEcCtD
Temsirolimus—Fatigue—Methotrexate—ankylosing spondylitis	0.000193	0.000789	CcSEcCtD
Temsirolimus—Headache—Betamethasone—ankylosing spondylitis	0.000193	0.000788	CcSEcCtD
Temsirolimus—Headache—Dexamethasone—ankylosing spondylitis	0.000193	0.000788	CcSEcCtD
Temsirolimus—Asthenia—Prednisone—ankylosing spondylitis	0.000192	0.000785	CcSEcCtD
Temsirolimus—Pain—Methotrexate—ankylosing spondylitis	0.000191	0.000782	CcSEcCtD
Temsirolimus—Pruritus—Prednisone—ankylosing spondylitis	0.000189	0.000775	CcSEcCtD
Temsirolimus—Diarrhoea—Prednisone—ankylosing spondylitis	0.000183	0.000749	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000183	0.000748	CcSEcCtD
Temsirolimus—Nausea—Dexamethasone—ankylosing spondylitis	0.000183	0.000747	CcSEcCtD
Temsirolimus—Nausea—Betamethasone—ankylosing spondylitis	0.000183	0.000747	CcSEcCtD
Temsirolimus—Dizziness—Prednisone—ankylosing spondylitis	0.000177	0.000724	CcSEcCtD
Temsirolimus—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000177	0.000723	CcSEcCtD
Temsirolimus—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000177	0.000723	CcSEcCtD
Temsirolimus—Vomiting—Prednisone—ankylosing spondylitis	0.00017	0.000696	CcSEcCtD
Temsirolimus—Rash—Prednisone—ankylosing spondylitis	0.000169	0.00069	CcSEcCtD
Temsirolimus—Dermatitis—Prednisone—ankylosing spondylitis	0.000169	0.00069	CcSEcCtD
Temsirolimus—Headache—Prednisone—ankylosing spondylitis	0.000168	0.000686	CcSEcCtD
Temsirolimus—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000165	0.000674	CcSEcCtD
Temsirolimus—Asthenia—Methotrexate—ankylosing spondylitis	0.000161	0.000656	CcSEcCtD
Temsirolimus—Nausea—Prednisone—ankylosing spondylitis	0.000159	0.00065	CcSEcCtD
Temsirolimus—Pruritus—Methotrexate—ankylosing spondylitis	0.000158	0.000647	CcSEcCtD
Temsirolimus—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000153	0.000626	CcSEcCtD
Temsirolimus—Dizziness—Methotrexate—ankylosing spondylitis	0.000148	0.000605	CcSEcCtD
Temsirolimus—Vomiting—Methotrexate—ankylosing spondylitis	0.000142	0.000582	CcSEcCtD
Temsirolimus—Rash—Methotrexate—ankylosing spondylitis	0.000141	0.000577	CcSEcCtD
Temsirolimus—Dermatitis—Methotrexate—ankylosing spondylitis	0.000141	0.000576	CcSEcCtD
Temsirolimus—Headache—Methotrexate—ankylosing spondylitis	0.00014	0.000573	CcSEcCtD
Temsirolimus—Nausea—Methotrexate—ankylosing spondylitis	0.000133	0.000543	CcSEcCtD
